Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Novartis Ag (NY: NVS )

84.43 USD +0.02 (+0.02%)
Official Closing Price Updated: 6:59 PM EDT, Oct 23, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 810,500
Open 84.63
Bid (Size) 82.80 (1)
Ask (Size) 85.51 (1)
Prev. Close 84.41
Today's Range 84.12 - 84.88
52wk Range 69.18 - 99.84
Shares Outstanding 2,330,800,000
Dividend Yield 3.53%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Banking on the Next Blockbuster Drug
- NetworkNewsWire Editorial Coverage 
From PR Newswire
NetworkNewsAudio – 180 Life Sciences Corp. Founders Leverage History of Success Developing, Selling New Drugs to Big Pharma
From InvestorBrandNetwork

Performance

YTD
-11.08%
-11.08%
1 Month
-2.17%
-2.17%
3 Month
-0.33%
-0.33%
6 Month
-5.76%
-5.76%
1 Year
-3.30%
-3.30%

More News

Read More
Banking on the Next Blockbuster Drug
From InvestorBrandNetwork
OLON Continues Strategic Collaboration With Novartis, Supporting the Expansion of the Africa Sickle Cell Disease Program to Kenya, Uganda and Tanzania
Tags Responsible Business & Employee Engagement tanzania NYSE:NVS
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Life Science Companies and the Bill & Melinda Gates Foundation: Commitments to Expanded Global Access for COVID-19 Diagnostics, Therapeutics, and Vaccines
Tags Corporate Social Responsibility COVID/19 Novartis
From 3BL Media: Corporate Social Responsibility, Energy and Health News
A Peek Into The Markets: US Stock Futures Edge Higher; Netflix Profit Misses Views
Tags Markets A Peek Into The Markets VZ
From Benzinga
Opthea IPO: What Investors Should Know About The Genentech, Regeneron Challenger
Tags REGN Jeremy Levin EYLEA
From Benzinga
December 18th Options Now Available For Novartis (NVS)
Tags Stocks
From Market News Video
Why Regeneron's Growth Opportunity Is Unappreciated
Tags Price Target Trading Ideas General
From Benzinga
Opthea IPO: What Investors Should Know About The Genentech, Regeneron Challenger
Tags Healthcare
From Blogs - TalkMarkets
October FDA, CDC Meetings On Coronavirus Vaccines Set Stage For Emergency Use Authorization
Tags Health Care Biotech Covid/19
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.